Ionis Pharmaceuticals (IONS) Exchange Rate Effect (2019 - 2026)
Ionis Pharmaceuticals' (IONS) quarterly Exchange Rate Effect came in at -$138000.0 in Q1 2026, down 159.48% year-on-year from $232000.0 in Q1 2025, and down 220.93% quarter-over-quarter from -$43000.0 in Q4 2025.
Ionis Pharmaceuticals (IONS) Exchange Rate Effect (2019 - 2026) Analysis & Trends
Ionis Pharmaceuticals' Exchange Rate Effect history runs 8 years deep, the most recent figure standing at -$138000.0 for Q1 2026.
- On a quarterly basis, Exchange Rate Effect fell 159.48% year-over-year to -$138000.0 in Q1 2026; TTM through Mar 2026 was $332000.0, a 354.79% increase from a year earlier, with the FY2025 full-year figure at $702000.0, up 357.14% from the prior year.
- Exchange Rate Effect declined to -$138000.0 in Q1 2026 per IONS's latest filing, from -$43000.0 in the prior quarter.
- Across five years, Exchange Rate Effect topped out at $595000.0 in Q2 2025 and bottomed at -$486000.0 in Q4 2024.
- The 5-year median for Exchange Rate Effect is -$43000.0 (2025), against an average of $13235.3.
- Across the five-year window, Exchange Rate Effect slumped 1800.0% in 2022 and soared 2686.96% in 2025, its largest moves.
- Year by year, Exchange Rate Effect stood at $546000.0 in 2022, then sank by 39.56% to $330000.0 in 2023, then plunged by 247.27% to -$486000.0 in 2024, then soared by 91.15% to -$43000.0 in 2025, then tumbled by 220.93% to -$138000.0 in 2026.
- Per Business Quant, the three latest IONS Exchange Rate Effect figures stand at -$138000.0 (Q1 2026), -$43000.0 (Q4 2025), and -$82000.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 619,347.27 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 19.32 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | -40.30 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -900,000.00 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Ionis Pharmaceuticals | 9.35 Bn | 7.43 Bn | 243.11 Mn | -138,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -138,000.00 |
| Mar 31, 2026 | -138,000.00 |
| Dec 31, 2025 | -43,000.00 |
| Dec 31, 2025 | -43,000.00 |
| Sep 30, 2025 | -82,000.00 |
| Sep 30, 2025 | -82,000.00 |
| Jun 30, 2025 | 595,000.00 |
| Jun 30, 2025 | 595,000.00 |
| Mar 31, 2025 | 232,000.00 |
| Mar 31, 2025 | 232,000.00 |
| Dec 31, 2024 | -486,000.00 |
| Dec 31, 2024 | -486,000.00 |
| Sep 30, 2024 | 350,000.00 |
| Sep 30, 2024 | 350,000.00 |
| Jun 30, 2024 | -23,000.00 |
| Jun 30, 2024 | -23,000.00 |
| Mar 31, 2024 | -114,000.00 |
| Mar 31, 2024 | -114,000.00 |
| Dec 31, 2023 | 330,000.00 |
| Dec 31, 2023 | 330,000.00 |